Adolore BioTherapeutics, Inc., (”Adolore” or the “Company”), a biotechnology company developing transformational opioid-free intracellularly-delivered treatments for chronic pain, today announced that ...
In patients starting opioid treatment for noncancer pain, being prescribed more opioids, getting repeated or refillable prescriptions, and being prescribed long-acting opioids were the top factors ...